Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe

Abstract

Among the nine nurses who indicated a preference for the Enbrel MYCLIC autoinjector, the most common reasons given were ''easy to operate'' (n = 6), followed by ''easy to grip'' (n = 5), ''audible feedback'' (n = 4), and ''concealing the injection needle'' (n = 4) (Fig. 5).